Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02415881
Title Phase I Panitumumab IRDye800 Optical Imaging Study
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eben Rosenthal
Indications

head and neck squamous cell carcinoma

Therapies

Panitumumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.